Exploring the role of the microbiota member Bifidobacterium in modulating immune-linked diseases

Ian O'Neill, Zoe Schofield, Lindsay J. Hall

Publikation: Beitrag in FachzeitschriftÜbersichtsartikelBegutachtung

74 Zitate (Scopus)

Abstract

The gut-associated microbiota is essential for multiple physiological processes, including immune development. Acquisition of our initial pioneer microbial communities, including the dominant early life genus Bifidobacterium, occurs at a critical period of immune maturation and programming. Bifidobacteria are resident microbiota members throughout our lifetime and have been shown to modulate specific immune cells and pathways. Notably, reductions in this genus have been associated with several diseases, including inflammatory bowel disease. In this review, we provide an overview of bifidobacteria profiles throughout life and how different strains of bifidobacteria have been implicated in immune modulation in disease states. The focus will be examining preclinical models and outcomes from clinical trials on immune-linked chronic conditions. Finally, we highlight some of the important unresolved questions in relation to Bifidobacterium-mediated immune modulation and implications for future directions, trials, and development of new therapies.

OriginalspracheEnglisch
Seiten (von - bis)333-349
Seitenumfang17
FachzeitschriftEmerging Topics in Life Sciences
Jahrgang1
Ausgabenummer4
DOIs
PublikationsstatusVeröffentlicht - Nov. 2017
Extern publiziertJa

Fingerprint

Untersuchen Sie die Forschungsthemen von „Exploring the role of the microbiota member Bifidobacterium in modulating immune-linked diseases“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren